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Background: Studies have demonstrated that autophagy pathways are activated in the brain after experimental
subarachnoid hemorrhage (SAH) and this may play a protective role in early brain injury. However, the contribution
of autophagy in the pathogenesis of cerebral vasospasm (CVS) following SAH, and whether up-regulated
autophagy may contribute to aggravate or release CVS, remain unknown. Cystatin C (CysC) is a cysteine protease
inhibitor that induces autophagy under conditions of neuronal challenge. This study investigated the expression of
autophagy proteins in the walls of basilar arteries (BA), and the effects of CysC on CVS and autophagy pathways
following experimental SAH in rats.
Methods: All SAH animals were subjected to injection of 0.3 mL fresh arterial, non-heparinized blood into the cisterna
magna. Fifty rats were assigned randomly to five groups: control group (n = 10), SAH group (n = 10), SAH + vehicle
group (n = 10), SAH + low dose of CysC group (n = 10), and SAH + high dose of CysC group (n = 10). We measured
proteins by western blot analysis, CVS by H&E staining method, morphological changes by electron microscopy, and
recorded neuro-behavior scores.
Results: Microtubule-associated protein light chain-3, an autophagosome biomarker, and beclin-1, a Bcl-2-interacting
protein required for autophagy, were significantly increased in the BA wall 48 h after SAH. In the CysC-handled group,
the degree of CVS, measured as the inner BA perimeter and BA wall thickness, was significantly ameliorated in
comparison with vehicle-treated SAH rats. This effect paralleled the intensity of autophagy in the BA wall
induced by CysC.
Conclusions: These results suggest that the autophagy pathway is activated in the BA wall after SAH and
CysC-induced autophagy may play a beneficial role in preventing SAH-induced CVS.
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Cerebral vasospasm (CVS) is a frequent and devastating
complication in patients with cisternal subarachnoid
hemorrhage (SAH) and represents a significant cause of
morbidity and mortality in neurosurgical patients [1]. Des-
pite promising therapeutic approaches, such as triple-H
therapy, calcium channel blockades, sodium nitroprusside,
and endothelin-receptor antagonists, successful treatment* Correspondence: nju_neurosurgery@163.com
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reproduction in any medium, provided the orafter SAH remains inadequate and the underlying patho-
genic mechanisms of CVS remain unidentified.
Autophagy is a cellular process of “self-digestion”.
When cells encounter stress conditions, such as nutrient
limitation, heat, oxidative stress, and/or the accumula-
tion of damaged or excess organelles and abnormal cel-
lular components, autophagy is induced as a degradative
pathway. The elimination of potentially toxic compo-
nents coupled with the recycling of nutrients aids in cell
survival [2]. Autophagy pathway activation may play an
important role in several central nervous system (CNS)
diseases, such as cerebral ischemia [3], hypoxia-ischemiaThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tracerebral hemorrhage [6], and SAH [7].
A previous report from our group [8] showed that au-
tophagy was significantly increased in the cerebral cortex
of rats and expression peaked at 24 h after induction of
SAH. Early brain injury (EBI), seen as brain edema,
blood–brain barrier impairment, cortical apoptosis, and
clinical behavior changes, were significantly ameliorated
by intracerebroventricular infusion of rapamycin (RAP,
an autophagy activator). However, 3-methyladenine (an
autophagy inhibitor) decreased expression of light chain-
3 (LC3) and beclin-1, and aggravated the EBI, suggesting
that the autophagy pathway may play a beneficial role in
EBI development after SAH. Nevertheless, a literature
review produced no studies that investigate the potential
contribution of autophagy to CVS following SAH. Previ-
ous reports suggested that autophagy may suppress in-
flammation, oxidant activity and apoptosis, which had
been shown to play a vital role in arterial wall thickening
and vasculature stiffening following SAH [7,8]. The aim
of the current study was to evaluate the expression of
the autophagy pathway in the basilar artery (BA) wall in
an experimental rat model of SAH and determine the




The animal use and care protocols, including all operation
procedures, were approved by the Animal Care and Use
Committee of Soochow University and conformed to the
Guide for the Care and Use of Laboratory Animals by the
National Institute of Health, China. Fifty male Sprague–
Dawley rats weighing from 300 to 350 g were purchased
from the Animal Center of the Chinese Academy of Sci-
ences (Shanghai, China). They were acclimated in a hu-
midified room and maintained on a standard pellet diet at
the Animal Center of Soochow University for at least 10
days. The temperature in both the feeding room and the
operation room was maintained at 25°C.
Subarachnoid hemorrhage (SAH) model
SAH was induced by the single-hemorrhage injection
model in rats as previously described [9]. Briefly, after
the animals were anesthetized with 4% chloral hydrate
(400 mg/kg body weight) a small suboccipital incision
was made, exposing the arch of the atlas, the occipital
bone, and the atlanto-occipital membrane. The cisterna
magna was tapped using a 27-gauge needle, and 0.3 mL
of cerebral spinal fluid were gently aspirated. Non-
heparinized freshly autologous blood (0.3 mL) from the
femoral artery was then injected aseptically into the cis-
terna magna over a period of 2 min. Immediately after
the injection of blood, the hole was sealed with glue toprevent fistula formation. The animals were tilted at a 30°
angle for 30 min with their heads down, in a prone pos-
ition, to permit pooling of blood around the BA. After-
wards, the rats were returned to their cages, the room
temperature was kept at 23±1°C, and 20 mL of 0.9% NaCl
was injected subcutaneously to prevent dehydration.
Experimental design
Fifty rats were assigned randomly to five groups: control
group (n = 10), SAH group (n = 10), SAH + vehicle
group (n = 10), SAH + low dose of CysC group (n = 10),
and SAH + high dose of CysC group (n = 10). CysC was
dissolved in normal sodium, and the final concentrations
were 2 μg/0.1 mL (low concentration) and 10 μg/0.1 mL
(high concentration), respectively. A volume of 0.1 mL
of the CysC dissolved in normal saline (NS) was admin-
istered directly into the cisterna magna 30 min before
the blood injection as a means of prevention and treat-
ment, while vehicle animals received an equal volume of
NS only into the cisterna magna.
The rats were re-anesthetized and euthanized 48 h
after blood injection by means of transthoracic cannula-
tion of the left ventricle; they were perfused with 300 mL
of phosphate-buffered saline solution under a pressure of
120 cmH2O. The BAs were immediately removed and 5 of
10 specimens in each group were placed in the fixative so-
lution (a mixture of 4% paraformaldehyde and 2.5% glutar-
aldehyde in 0.1 M phosphate buffer, pH 7.4) for 24 h for
histopathological examination and morphometric analysis,
and another five specimens were frozen in liquid nitrogen
for Western blot analysis.
Morphometric measurements
The BA luminal perimeter and wall thickness for each
specimen was measured using a digitized image analysis
system with Image-pro Plus software. The specimens for
light microscopy study were dehydrated in graded etha-
nol, embedded in paraffin, sectioned, and stained with
hematoxylin and eosin. Light microscopic sections of ar-
teries were projected as digitized video images. The
inner perimeters of the vessels were measured by tracing
the luminal surface of the intima. The thickness of the
vessel wall was determined by taking four measurements
of each artery that extended from the luminal surface of
the intima to the outer limit of the media, to avoid in-
clusion of the adventitia. The four measurements were
averaged.
Western blotting analysis
The frozen brain samples were mechanically lysed in
20 mM Tris, pH 7.6, containing 0.2% sodium dodecyl sul-
fate (SDS), 1% Triton X-100, 1% deoxycholate, 1 mM
phenylmethylsulphonyl fluoride, and 0.11 IU/mL apro-
tinin (all purchased from Sigma-Aldrich). Lysates were
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concentration was estimated by the Bradford method
using the Nanjing Jiancheng protein assay kit (Nanjing
Jiancheng Bioengineering Institute, Nanjing, China). The
samples (60 μg per lane) were separated by 8% SDS poly-
acrylamide gel electrophoresis and electro-transferred
onto a polyvinylidene-difluoride membrane (Bio-Rad Lab,
Hercules, CA, USA). The membrane was blocked with 5%
skimmed milk for 2 h at room temperature, incubated
overnight at 4°C with primary antibodies directed against
LC-3 and beclin-1 (Santa Cruz Biotechnology, Santa Cruz,
CA, USA) at the dilutions of 1:200 and 1:150, respectively.
Glyceraldehyde-3-phosphate dehydrogenase (diluted in
1:6,000, Sigma-Aldrich) was used as a loading control.
After the membrane was washed six times, for 10 min
each time, in PBS plus Tween 20 (PBST), it was incubated
in the appropriate HRP-conjugated secondary antibody
(diluted 1:400 in PBST) for 2 h. The blotted protein bands
were visualized by enhanced chemiluminescence Western
blot detection reagents (Amersham, Arlington Heights,
IL, USA) and were exposed to X-ray film. Developed films
were digitized using an Epson Perfection 2480 scanner
(Seiko Corp, Nagano, Japan). Optical densities were
obtained using Glyko Bandscan software (Glyko, Novato,
CA, USA). The tissue of five animals in each group was
used for Western blot analysis at 48 h after SAH.
Neurologic scoring
Three behavioral activity examinations (Table 1) were
performed at 48 h after SAH using the scoring system
reported previously to record appetite, activity, and
neurological deficits [10].
Transmission electron microscopy
The brain tissue adjacent to the clotted blood was ana-
lyzed in this experiment. Samples for electron microscopy
were fixed in phosphate-buffered glutaraldehyde (2.5%)
and osmium tetroxide (1%). Dehydration of the cortex
was accomplished in acetone solutions at increasing con-
centrations. The tissue was embedded in an epoxy resin.Table 1 Behavior and activity scores
Category Behavior Score
Appetite Finished meal 0
Left meal unfinished 1
Scarcely ate 2
Activity Walk and reach at least three corners of the cage 0
Walk with some stimulations 1
Almost always lying down 2
Deficits No deficits 0
Unstable walk 1
Impossible to walk 2Semi-thin (1 μm) sections through the sample were then
made and stained with toluidine blue; 600 Å-thin sections
were made from a selected area of tissue defined by the
semi-thin section, and these were stained with lead citrate
and uranyl acetate. Brain ultrastructure was observed
under a transmission electron microscope (JEM-1200X).
Statistical analysis
All values are expressed as means ± SEM. Statistical differ-
ences between the groups were compared using one-way




There were no significant differences in body weight,
temperature, or injected arterial blood gas data among
the experimental groups (data not shown). After induction
of SAH, all animals stopped breathing for about 15 s. The
mortality rate of rats was 0% (0/10 rats) in the control
group and 11% (5/45 rats) in the remaining groups. Wide-
spread distribution of blood was seen in the basal cisterns,
circle of Willis, and along the ventral brainstem 48 h after
SAH. There were no blood clots in the control group
(Figure 1).
Morphometric vasospasm
The inner perimeter of BAs in the SAH group and ve-
hicle group became smaller, and the BA wall thickness
became thicker than in the control group (P <0.01). We
observed moderate arterial narrowing and reduction of
the intima in the above two groups. Compared with
SAH and vehicle groups, the inner perimeter of the BA
in the treatment group was expanded and thickness of
BA walls decreased with a statistically significantFigure 1 Ventral view of typical brains in control group and
SAH group. (A) No blood clot was present in the control group. (B)
Widespread distribution of blood was seen in the basal cisterns, the
circle of Willis, and along the ventral brainstem in the SAH group.
Figure 2 Changes in the cross-sectional area of basilar arteries (BAs) in the experimental SAH model. Representative images of cross-
sectional areas of the BAs of the control group or rats subjected to SAH alone or SAH plus intracisternal injection with vehicle or CysC. (A) No
corrugation and non-convoluted internal elastic lamina were observed in the control group; (B) Severe vasospasm could be detected in the SAH
group; (C) Representative images showing luminal narrowing, increased wall thickness, and corrugation of the tunica intima in SAH + vehicle
group. (D-E) The BA cross-sectional area was significantly increased in the SAH+ CysC group which was dose-dependent.
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(compared with low concentration group, P <0.05)
(Figures 2 and 3).
Western blot analysis for detecting autophagy activation
after SAH
Western blot analysis showed that the level of LC3 and
beclin-1 in the BA wall was low in the control group.
The expression of LC3 and beclin-1 was significantly in-
creased at 48 h after blood injection in the SAH group
and SAH + vehicle group (P <0.05). There was no statis-
tically significant difference between the SAH group and
SAH + vehicle group (P >0.05). After CysC injection, the
level of LC3 and beclin-1 was markedly upregulated in
animals of SAH + CysC group, especially in SAH + high
concentration of CysC group (P <0.01) (Figure 4).
Behavior and activity scores
As compared with the control group, clinical behavior
function impairment caused by SAH was evident inFigure 3 The inner perimeter (A) and the wall thickness (B) of basal a
vehicle group. Decreased vasospasm was observed in rats treated with Cys
SAH + vehicle group; ##P <0.01 compared with SAH + vehicle group.SAH subjects (P <0.01). No significant difference was
seen between the SAH group and SAH + vehicle group
(P >0.05). CysC-treated rats showed better performance
in this scale system than vehicle-treated rats 48 h after
SAH, and the difference was statistically significant
(P <0.01). There was no statistically significant dif-
ference between low and high concentration of CysC
groups (P >0.05) (Table 2).Transmission electron microscopy observations
As shown in Figure 5, neurons and glial cells in the con-
trols appeared healthy with normal endoplasmic reticulum,
mitochondria, lysosomes, and nucleus. In contrast, diverse
morphological changes were found in the cortex 48 h fol-
lowing SAH induction. Superficial neuroglial cells showed
severe damage, such as cell harboring, multiple cytoplas-
mic vacuoles, cells completely lacking cytoplasmic con-
tents, and shrunken nuclei with condensed chromatin.
Numerous neurons displayed multiple vacuole-related
structures containing electron-dense material or doublerteries (BAs). Severe vasospasm was shown in SAH group and SAH +
C. **P <0.01 compared with control group; #P <0.05 compared with
Figure 4 Expressions of LC3 and beclin-1 in the BA walls in the
control (n = 5, Lane 1), SAH (n = 5, Lane 2), SAH + vehicle (n = 5,
Lane 3), SAH + low dose of CysC (n = 5, Lane 4), and SAH + high
dose of CysC (n = 5, Lane 5) groups. Upper: Representative
autoradiograph showing protein expression following SAH by
western blot. We detected LC3 at 16 kDa, beclin-1 at 52 kDa, and
the loading control glyceraldehyde-3-phosphate dehydrogenase at
36 kD. Bottom: Quantitative analysis of the western blot results for
the levels of LC3 and beclin-1. The expression of autophagy-
related proteins was low in the control group. The expression of
autophagy proteins was significantly increased in the SAH and
SAH + vehicle experimental groups compared with controls
(P <0.05). The increased expression was further markedly
upregulated by CysC treatment (P <0.01). *P <0.05 compared with
control group; **P <0.01 compared with control group; ns P >0.05
compared with SAH + vehicle group; #P <0.05 compared with SAH +
vehicle group; ##P <0.01 compared with SAH + vehicle group.
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nificantly ameliorated by CysC administration.
Discussion
CVS is a common and potentially devastating complica-




SAH + vehicle 2.6ns
SAH + low dose of CysC 1.7**
SAH + high dose of CysC 1.5***
*P <0.01, compared with control group; nsP >0.05, compared with SAH group;
**P <0.01, compared with SAH + vehicle group; ***P <0.05, compared with SAH +
low dose of CysC group.significant cause of morbidity and mortality in these pa-
tients [11]. In this present study, we investigated the role
of CysC on CVS following SAH in rats, and explored
possible mechanisms behind its actions. We made the
following novel observations: 1) The pathological
changes, including morphological changes, artery-
narrowing, and thickening of BA wall, suggest that CVS
occurs after SAH; 2) The level of expression of autoph-
agy related proteins, LC-3, and Beclin-1, were low in the
normal control group; 3) Autophagy was expressed in
the BA wall during early stage after SAH in rats,
suggesting that autophagy may participate in the patho-
logical course of CVS; and 4) In CysC-handled group,
the degree of CVS (inner perimeter of BA, BA wall
thickness, and the clinical behavior function) was signifi-
cantly ameliorated and this effect was paralleled with the
intensity of autophagy in the BA wall induced by CysC.
These findings suggest, for the first time, that SAH may
induce vascular autophagy in the spasmed artery and
might play a role in the pathogenesis of CVS. The thera-
peutic benefit of post-SAH CysC administration might
be due to its salutary effect on modulating the autoph-
agy signaling pathway.
CysC is an endogenous cysteine protease inhibitor,
ubiquitously expressed and secreted in body fluids [12].
By inhibiting cysteine proteases such as cathepsins B, H,
K, L, and S, it has a broad spectrum of biological roles
in numerous cellular systems, with growth promoting
activity, inflammation down-regulating function, and
anti-viral and anti-bacterial properties [13]. It is involved
in numerous and varied processes such as cancer, renal
diseases, diabetes, and epilepsy, and neurodegenerative
diseases such as Alzheimer’s disease.
Previous reports have shown that CysC plays a pro-
tective role in CNS diseases, such as Alzheimer's disease
[14], focal brain ischemia [15], and progressive myo-
clonic epilepsy type 1, but did not elucidate the mechan-
ism(s) of neuroprotection. Recently, Tizon et al. [14]
demonstrated that CysC plays a protective role under
conditions of neuronal challenge by inducing autophagy
via mTOR inhibition. This neuroprotective function was
prevented by inhibiting autophagy with beclin-1 siRNA
or 3-methyladenine.
Accumulating evidence shows that the autophagy
pathway plays an important role in the pathogenesis of
different diseases in the CNS, such as cerebral ischemia
[3], traumatic brain injury [5], experimental intracerebral
hemorrhage [6], and hypoxia-ischemia brain injury [4].
In the SAH field, Lee et al. [7] demonstrated a signifi-
cantly increased autophagic activity in the cortex in EBI
after SAH. Our previous study [8] indicated that autoph-
agy was significantly increased in the cortex of Sprague–
Dawley rats and their expressions peaked 24 h after SAH.
EBI such as brain edema, blood–brain barrier impairment,
Figure 5 Electron micrographs of the cortex at 48 h following sham operation (A), SAH induction (B and C), vehicle treatment (D), and
CysC treatment (E, F, G, and H). (A) In the control group, the glial cells were normal with integrated nuclear membrane. No swelling was found
in endoplasmic reticulum and mitochondria. The electron density was normal in cytoplasm. (B) In the SAH group, the nuclear membrane was
not integrated and the cytoplasm component entered the cell nucleus pushing the nuclear membrane. (C) In the SAH group, the nuclear
membrane dissolved and shrank with nucleolar margination and chromatic agglutination in the glia cells. The staining was uneven with more
endolysosome in the cytoplasm. (D) In the vehicle group, the endotheliocyte swelled in the capillary with apoptotic neurons and glial cells. (E) In
the low dose CysC group, the nuclear membrane was more integrated than the SAH group with a little chromatic agglutination at the border of
the nuclear membrane. In the cytoplasm, some of the mitochondria were swollen. (F) In the low dose CysC group, mild demyelination was
found with the myelin sheath and mitochondria morphology was better than in the vehicle treated group. (G-H) In the high dose group, the
myelin sheath was better than that in the SAH group surrounded with some stromal cells.
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nificantly ameliorated by intracerebroventricular infu-
sion of rapamycin (RAP, autophagy activator), while
3-methyladenine decreased expression of LC3 and
beclin-1, and aggravated the EBI, suggesting that the
autophagy pathway may play a beneficial role in EBI
development after SAH. However, until now, no study
has been found in the literature investigating the po-
tential contribution of autophagy to CVS following
SAH.
Autophagy also plays a housekeeping role in removing
misfolded or aggregated proteins, clearing damaged or-
ganelles, such as mitochondria, endoplasmic reticulum
and peroxisomes, and eliminating intracellular patho-
gens [16]. Failure of autophagy induces pleiotropic phe-
notypes leading to cell death, impaired differentiation,
oxidative stress, toxic protein and organelle accumula-
tion and persistence, tissue damage, inflammation, and
mortality in mammals. This can lead to tissue dysfunc-
tion, inflammatory conditions, and cancer [17]. Previous
publications suggested that autophagy can suppress in-
flammation [17,18], antioxidant activity [19-21], and
anti-apoptosis [22,23] to maintain cellular homeostasis.
Inflammation, oxidative stress, and apoptosis were con-sidered to be a major component of SAH, and may con-
tribute to the pathophysiology of both CVS and EBI
[24]. It is indicated that the activation of autophagy may
also have a beneficial role in the development of CVS
following SAH. In this study, our data demonstrated that
there is a significant increase of autophagy proteins in
the BA wall 48 h following SAH induction, and the ex-
pression of autophagy was even higher after administra-
tion of CysC. In CysC-handled group, the degree of
CVS, such as the inner perimeter of the BA and the BA
wall thickness, was significantly ameliorated in compari-
son with vehicle-treated SAH rats, and this effect was
paralleled with the intensity of autophagy in the BA wall
induced by CysC.
Conclusions
To the best of our knowledge, this is the first study to
demonstrate the protective contribution of autophagy to
CVS in the experimental SAH model, which suggests
that the autophagy pathway may in fact play a significant
role in CVS following SAH. Activation of autophagy in-
duced by CysC resulted in attenuation of CVS in SAH
models. Further studies evaluating the exact mechanism
of autophagy pathway within CVS are warranted.
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